Cargando…
Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells in vitro and in vivo
Glioblastoma (GBM) is the most frequent and aggressive brain tumor in adults. In spite of advances in diagnosis and therapy, the prognosis of patients with GBM has remained dismal. The fast recurrence and multi-drug resistance are some of the key challenges in combating brain tumors. Glioma stem cel...
Autores principales: | Yu, Zhiyun, Zhao, Gang, Xie, Guifang, Zhao, Liyan, Chen, Yong, Yu, Hongquan, Zhang, Zhonghua, Li, Cai, Li, Yunqian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741740/ https://www.ncbi.nlm.nih.gov/pubmed/26431379 |
Ejemplares similares
-
Temozolomide in combination with metformin act synergistically to inhibit proliferation and expansion of glioma stem-like cells
por: YU, ZHIYUN, et al.
Publicado: (2016) -
Synergistic Effect of Perampanel and Temozolomide in Human Glioma Cell Lines
por: Salmaggi, Andrea, et al.
Publicado: (2021) -
Piperine synergistically enhances the effect of temozolomide against temozolomide-resistant human glioma cell lines
por: Jeong, Somi, et al.
Publicado: (2020) -
Temozolomide in malignant glioma
por: Dresemann, Gregor
Publicado: (2010) -
Arsenic trioxide inhibits glioma cell growth through induction of telomerase displacement and telomere dysfunction
por: Cheng, Ye, et al.
Publicado: (2016)